US SB487 | 2009-2010 | 111th Congress
Status
Spectrum: Strong Partisan Bill (Democrat 10-1)
Status: Introduced on February 26 2009 - 25% progression, died in chamber
Action: 2009-02-26 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S2562-2563)
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on February 26 2009 - 25% progression, died in chamber
Action: 2009-02-26 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S2562-2563)
Text: Latest bill text (Introduced) [PDF]
Summary
Stem Cell Research Enhancement Act of 2009 - Amends the Public Health Service Act to require the Secretary of Health and Human Services to conduct and support research that utilizes human embryonic stem cells, regardless of the date on which the stem cells were derived from a human embryo. Limits such research to stem cells that meet the following requirements: (1) the stem cells were derived from human embryos donated from in vitro fertilization clinics, were created for the purposes of fertility treatment, and were in excess of the needs of the individuals seeking such treatment; (2) prior to donation, it was determined that the embryos would never be implanted in a woman and would otherwise be discarded; and (3) the individuals seeking fertility treatment donated the embryos with written informed consent and received no financial or other inducements. Requires the Secretary to develop techniques for the isolation, derivation, production, or testing of stem cells that are capable of producing all or almost all of the cell types of the developing body and may result in improved understanding of treatments for diseases and other adverse health conditions, but that are not derived from a human embryo. Requires the Secretary to: (1) provide guidance concerning the next steps required for additional research; (2) prioritize research with the greatest potential for near-term clinical benefit; and (3) take into account techniques outlined by the President's Council on Bioethics and any other appropriate techniques and research.
Title
Stem Cell Research Enhancement Act of 2009
Sponsors
Sen. Barbara Boxer [D-CA] | Sen. Christopher Dodd [D-CT] | Sen. Dianne Feinstein [D-CA] | Sen. Tom Harkin [D-IA] |
Sen. Orrin Hatch [R-UT] | Sen. Edward Kennedy [D-MA] | Sen. John Kerry [D-MA] | Sen. Harry Reid [D-NV] |
Sen. Jeanne Shaheen [D-NH] | Sen. Arlen Specter [D-PA] | Sen. Debbie Stabenow [D-MI] |
History
Date | Chamber | Action |
---|---|---|
2009-02-26 | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S2562-2563) | |
2009-02-26 | Sponsor introductory remarks on measure. (CR S2562) |
Same As/Similar To
HB873 (Related) 2009-02-09 - Referred to the Subcommittee on Health.
HB4808 (Related) 2010-03-10 - Referred to the House Committee on Energy and Commerce.
HB4808 (Related) 2010-03-10 - Referred to the House Committee on Energy and Commerce.
Subjects
Administrative law and regulatory procedures
Cell biology and embryology
Department of Health and Human Services
Medical ethics
Medical research
National Institutes of Health (NIH)
Research administration and funding
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/111th-congress/senate-bill/487/all-info |
Text | https://www.congress.gov/111/bills/s487/BILLS-111s487is.pdf |